For citations:
Rakhimov R.R., Sultanbaev A.V., Menshikov K.V., Nasretdinov A.F., Musin Sh.I., Lipatov O.N., Suravatkin V.A. The effectiveness of the combination of lenvatinib and everolimus in metastatic renal cell carcinoma in patients with resistance to targeted treatment in real clinical practice. Medical alphabet. 2024;(7):18-25. (In Russ.) https://doi.org/10.33667/2078-5631-2024-7-18-25